Keywords: Chronic hepatitis, Hemangioma, Hepatectomy, Hepatocellular
cancer, Radiologic imaging.
Researchers reported on their analysis of past prevalence of HCV, NASH, and alcoholic cirrhosis and prediction of future trends and their effect on hepatocellular
The United States Food and Drug Administration (USFDA) has approved US-based Eli Lilly's CYRAMZA for the treatment of hepatocellular
carcinoma, it was reported yesterday.
10,278,960 entitled "Sphingosine Pathway Modulating Compounds for the Treatment of Cancers" that is directed to methods for treating hepatocellular
carcinoma, the most common human liver cancer, using the compound Ozanimod.
Biopharmaceutical firms LSK BioPharma and Jiangsu Hengrui Medicine Co Ltd (SHA:600276) on Monday jointly announced US FDA clearance to launch a clinical trial in advanced hepatocellular
carcinoma (HCC) patients in the US.
DIRECT-ACTING ANTIVIRALS significantly decrease risk of hepatocellular
carcinoma and mortality in persons with hepatitis C, according to results of the first prospective, longitudinal study to evaluate the effect of the drugs on complications related to the infection.
KEYWORDS: Direct Acting Antiviral Agents, Hepatocellular
carcinoma, Sustained Virological Response.
Background: The diagnosis and treatment of small hepatocellular
carcinoma (HCC) play a vital role in the prognosis of patients with HCC.
carcinoma, Bone metastasis, Bone scintigraphy.
Fibrolamellar carcinoma (FLC) is a unique primary hepatocellular
malignancy, encompassing patient demographics, risk factors, and tumor markers distinct from those of classical hepatocellular
Background: The aim of this study is to evaluate the outcomes and prognostic factors in patients with hepatocellular
carcinoma (HCC) and Child-Turcotte-Pugh (CTP) class B liver function after stereotactic ablative radiotherapy (SABR).
Transarterial chemoembolization (TACE) is one of the well-established and widely performed treatments for hepatocellular
carcinoma (HCC), especially in patients with intermediate or advanced stage tumors without operability (1-3).